News ArchivesRead News
Parkinson's Virtual Reality Gait Training Device Improves Quality of Life
Thursday January 29, 2009
PRWeb - Parkinson's disease and Multiple Sclerosis patients are discovering first-hand that daily exercise with a new virtual reality device, the GaitAid Virtual Walker, has a positive effect on their walking ability, minimizing balance problems and improving quality of life.
Yoram Baram, a computer science professor and incumbent of the Roy Matas / Winnipeg Chair in Biomedical Engineering at the Technion, Israel Institute of Technology has collaborated with several neurologists specializing in treating Parkinson's disease, Multiple Sclerosis and other movement disorders, in developing and testing a new, non-invasive training device designed to proactively minimize freezing and balance problems during walking. The noticeable physical and mental improvement of patients participating in clinical studies led Baram to bring the GaitAid device to market as a FDA registered medical device and is offering the device for a trial period on his company's website (www.medigait.com).
A Professor of Neurology and Director of the Movement Disorder Clinic of The Rambam Medical Center, Yehudit Aharon, M.D., specializes in the treatment of Parkinson's Disease. "The development of this device has been invaluable to my patients. They have better balance, reduction of freezing and improved confidence," states Dr. Aharon.
Parkinson's and Multiple Sclerosis patients participating in Baram's GaitAid training notice improvement in walking, and maintaining balance. According to a GaitAid device user, "This device gives me the feeling that I am taking control of my illness. I got my confidence back and can actually enjoy going out for a walk without the fear of falling down. But most importantly, my mental state of being is much more positive and I'm more independent."
Professor of Neurology and Director of the Center for Multiple Sclerosis and Brain of the Carmel Medical Center, Ariel Miller, M.D., specializes in the treatment of Multiple Sclerosis. "The results clearly indicate that the device helps patients with MS control their gait. The degree of improvement is proportional to the degree of impairment. The results support the potential role of the device as a rehabilitation modality in MS, and substantiate their specific implementation in efforts to alleviate, improve, and restore mobility in patients with gait disturbances due to neurological disorders in general", states Dr. Miller.
Prof. Baram states, "My biggest joy is when a person using my GaitAid device calls me to say 'Thank you, Yoram; Using the GaitAid has changed my life."
The user-friendly device includes special glasses and earphones which provide sensory feedback of visual images and sounds in response to the patient's movements. Training involves walking with the device for up to twenty minutes. These training sessions evoke a neuroplastic response in the patient's brain, creating new healthy neural circuits which by-pass the disease-damaged areas.
Parkinson's Disease remains a mystery of medical science. For reason's unknown, certain brain cells stop producing a substance called Dopamine, which affects an individual's movement, strength and balance. There is currently no cure, though stem cell research offers future promise.
Emerging scientific evidence confirms that movement lessens neurological deterioration that contributes to Parkinson's and Multiple Sclerosis progression.
The idea for the GaitAid project was sparked 12 years ago while Professor Baram was designing a mechanism for NASA to navigate low-flying helicopters around obstacles. The concept of the design, which Baram later applied to the medical device, is that the optical images of objects help the observer navigate, stabilize and pace movement in space.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright